Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (40)
  • Allergen immunotherapy (81)
  • AllergoOncology (14)
  • Allergy asthma and a sport (4)
  • Allergy diagnosis (222)
  • Allied health and primary care (19)
  • Anaphylaxis (112)
  • Artificial Intelligence (12)
  • Asthma (138)
  • Basic immunology (57)
  • Biologicals (75)
  • Biomarkers (54)
  • Comparative veterinary allergology (1)
  • COVID19 (9)
  • Dermatology (123)
  • Drug allergy (158)
  • ENT (24)
  • Environmental allergy and climate change (30)
  • Eosinophilic esophagitis (21)
  • Epidemiology (64)
  • Epithelial cell biology (8)
  • Food allergy (193)
  • Genomics and proteomics (17)
  • Immune deficiencies and autoimmunity (77)
  • Immunomodulation and nutrition (13)
  • Infections (24)
  • Insect venom hypersensitivities (19)
  • Mastocytosis and mast cells (23)
  • Microbiome (8)
  • Occupational allergy (24)
  • Ocular allergy (5)
  • One Health (13)
  • Pediatrics (131)
  • Prevention (38)
  • Systems medicine (13)
Poster available until
  • Until platform closure (46)
Poster categories
  • x e-Thematic Poster Session (93)
  • x Thematic Poster Session (980)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (15)
  • L-TPS03 (14)
  • L-TPS04 (12)
  • L-TPS05 (13)
  • L-TPS06 (8)
  • L-TPS07 (11)
  • L-TPS08 (7)
  • L-TPS09 (13)
  • L-TPS10 (13)
  • L-TPS11 (12)
  • L-TPS12 (14)
  • L-TPS13 (13)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (5)
  • L-TPS17 (13)
  • L-TPS18 (9)
  • L-TPS19 (10)
  • L-TPS20 (12)
  • L-TPS21 (12)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (14)
  • TPS04 (9)
  • TPS05 (15)
  • TPS06 (11)
  • TPS07 (13)
  • TPS08 (9)
  • TPS09 (9)
  • TPS10 (16)
  • TPS11 (13)
  • TPS12 (12)
  • TPS13 (11)
  • TPS14 (12)
  • TPS15 (15)
  • TPS16 (15)
  • TPS17 (12)
  • TPS18 (10)
  • TPS19 (7)
  • TPS20 (11)
  • TPS21 (5)
  • TPS22 (3)
  • TPS23 (4)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (16)
  • TPS30 (14)
  • TPS31 (15)
  • TPS32 (16)
  • TPS33 (14)
  • TPS34 (17)
  • TPS35 (15)
  • TPS36 (12)
  • TPS37 (15)
  • TPS38 (13)
  • TPS39 (14)
  • TPS40 (13)
  • TPS41 (9)
  • TPS42 (12)
  • TPS43 (12)
  • TPS44 (14)
  • TPS45 (12)
  • TPS46 (8)
  • TPS47 (7)
  • TPS48 (5)
  • TPS49 (5)
  • TPS51 (1)
  • TPS52 (12)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (1)
  • TPS57 (11)
  • TPS58 (1)
  • TPS59 (12)
  • TPS60 (9)
  • TPS61 (1)
  • TPS62 (8)
  • TPS63 (10)
  • TPS64 (11)
  • TPS65 (7)
  • TPS66 (9)
  • TPS67 (9)
  • TPS68 (19)
  • TPS69 (8)
  • TPS70 (9)
  • TPS71 (11)
  • TPS72 (6)
  • TPS73 (5)
  • TPS75 (4)
1073 results
Thumbnail

D1.349 - Age-related fungal molecular clusters revealed by allergen chip assay in Eastern France

Thumbnail

D1.352 - Assessment of the Efficacy of Mepolizumab in Modulating Disease Activity in Eosinophilic Granulomatosis with Polyangiitis: A 12-Month Analysis Evaluating the Birmingham Vasculitis Activity Score

Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.372 - Potential blood biomarkers of disease activity in patients with chronic spontaneous urticaria

Thumbnail

D1.375 - Ciclosporin for omalizumab-refractory CSU in a Paediatric population in Cork University Hospital: a case series

Thumbnail

D1.376 - Emerging inmunomodulatory agents for atopic dermatitis

Thumbnail

D1.377 - Berotralstat effectively controls a type 2 Hereditary Angioedema patient, refractory to other long-term prophylaxis treatments – Case report

Thumbnail

D1.378 - Evaluating the efficacy of dupilumab treatment for atopic dermatitis across geographic areas: A systematic review and meta-regression analysis

Thumbnail

D1.379 - AllergoOncology: Generation of Equinized Anti-PD-L1 mAbs with Specific Equine Constant Regions by MOE-PCR Ligation-Independent Cloning (LIC)

Thumbnail

D1.380 - Quicker EASI 75 or greater decline of DLQI - is it significant? Comparison of dupilumab treatment among children and adults in two centres in Cracow

Thumbnail

D1.383 - Nonimmediate hypersensitivity reaction to Lanadelumab in a patient with Hereditary Angioedema: a case report

Thumbnail

D1.384 - Long-term Prophylaxis with Lanadelumab in Hereditary and Acquired Angioedema: A Single-Center Retrospective-Prospective “Real-Life” Analysis

Thumbnail

D1.385 - Dupilumab Treatment Effects on Atopic Manifestations in Patients with Inborn Errors of Immunity

Thumbnail

D1.386 - Impact of dupilumab on allergen specific immunoglobulin E production

Thumbnail

D1.39 - Differential Diagnosis of Perioperative Anaphylaxis: The Hidden Role of Chlorhexidine

Thumbnail

D1.402 - Study of lymphocyte populations and subpopulations in patients with long-COVID with reactivation of herpesvirus type 6 infection

Thumbnail

D1.408 - Relationship between excessive screen use and allergic diseases

Thumbnail

D1.410 - Diet-induced obesity in children population

Thumbnail

D1.411 - The importance of breathing exercises in the rehabilitation of allergic asthma in children

Thumbnail

D1.416 - Pediatric Mast Cell Activation Syndrome: A Case Series Highlighting Varied Clinical Responses to Treatment and natural history

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM